Insight Molecular Diagnostics Inc. Common Stock IMDX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$47.84M+4.7% | -$50.22M+17.4% | -$60.78M+4.2% | -$63.42M-9.0% | -$58.21M+4.1% | ||
| $2.34M+6.7% | $2.19M+1.0% | $2.17M+14.0% | $1.9M+15.5% | $1.65M+11.6% | ||
| $2.36M+6.4% | $2.22M+11.1% | $2M+3.7% | $1.93M+6.5% | $1.81M+3.1% | ||
| -$23.98M-8.1% | -$22.18M-0.9% | -$21.99M+4.5% | -$23.02M-1.4% | -$22.7M-9.7% | ||
| $3.49M+9.6% | $3.19M+65.9% | $1.92M+101% | $957K+19.8% | $799K+54.8% | ||
| -$3.49M-9.6% | -$3.19M-66.2% | -$1.92M-101% | -$953K-19.9% | -$795K-55.3% | ||
| —— | —— | —— | —— | $49.24M+138% | ||
| —— | —— | —— | —— | —— | ||
| -$27.48M-8.3% | -$25.37M-6.1% | -$23.91M+0.3% | -$23.98M-2.0% | -$23.5M-10.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insight Molecular Diagnostics Inc. Common Stock generate?
- Insight Molecular Diagnostics Inc. Common Stock (IMDX) generated -$24.0M in operating cash flow over the trailing twelve months.
- What is Insight Molecular Diagnostics Inc. Common Stock's free cash flow?
- After $3.5M of capital expenditures, Insight Molecular Diagnostics Inc. Common Stock's free cash flow was -$27.5M over the trailing twelve months, down 16.9% year over year.
- Where does Insight Molecular Diagnostics Inc. Common Stock's cash flow data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
